SF0056H3001

This amendment fundamentally changes the bill from regulating kratom products to prohibiting both kratom and tianeptine products that lack FDA approval, shifting enforcement to the Division of Criminal Investigation.

• Changes the bill's title and purpose from 'regulating' kratom to 'prohibiting' kratom and tianeptine products. (Page 1, lines 5-7, 9, 24-25)
• Replaces references to 'testing and use' with 'dispensing, distributing, manufacturing or producing' and adds tianeptine as a prohibited substance. (Page 1, lines 11-14)
• Removes provisions allowing regulation of kratom products and instead establishes a blanket prohibition on non-FDA-approved kratom and tianeptine products. (Page 1, lines 3-4, 16-18; Pages 2-15 deleted entirely)
• Adds both criminal and civil penalties for violations, rather than criminal penalties only. (Page 1, line 20)
• Replaces the entire regulatory framework with a new 'Act to Protect Communities from Unregulated Substances' that prohibits dispensing, distributing, manufacturing, producing, or selling non-FDA-approved kratom or tianeptine products, with a criminal penalty of up to $750 and enforcement authority for seizure, forfeiture, and license suspension. (Page 16, lines 29-9 (new text))
• Changes enforcement from the Department of Health to the Division of Criminal Investigation, including responsibility for testing equipment and rule promulgation. (Page 17, lines 1, 5-6, 13-26)
• Changes the appropriation timeline from July 1, 2026 to the effective date of the act. (Page 17, lines 21-22)

AI-generated summary · Verify against the amendment text (PDF) · Notice a problem? Let us know